Lee D. Merritt MD | New American
The COVID-19 vaccines were released on an emergency basis before being properly tested. With the passage of time, the effects of these experimental drugs look increasingly dismal.
Many Americans have heard the news account of Dr. Gregory Michael, a 56-year-old Florida physician who, after receiving his first dose of the Pfizer/BioNTech COVID vaccine on December 18 of last year, was hospitalized with a blood disorder and spontaneous bleeding. In spite of being treated by a team of physicians, he died of a brain bleed due to total loss of his platelets — the little blood cells that stop bleeding. By February 10, 2021, 36 similar cases were reported in the mainstream media. Pfizer said in a statement that it was “aware of the death,” adding, “We are actively investigating this case, but we don’t believe at this time that there is any direct connection to the vaccine.”
Pfizer made this “finding” despite several unusual circumstances of the case. First, the low-platelet disorder known to most doctors as idiopathic thrombocytopenic purpura (ITP) most commonly affects children, and generally follows a viral illness. Only 10 percent of ITP cases occur in adults, who usually pre-sent with a slow onset form of the disorder, referred to as chronic ITP. The disorder usually starts by easy bleeding, such as slow oozing from gums or the nose, or bruises showing up without trauma. Rarely do platelets drop below 20,000 per microliter (normal levels are 200,000-500,000 per microliter), and generally treatment either reverses the disease or prolongs life for years in spite of the problem.
READ FULL ARTICLE ON NEW AMERICAN
